{"id":9667,"date":"2026-03-18T11:22:37","date_gmt":"2026-03-18T03:22:37","guid":{"rendered":"https:\/\/regask.com\/?p=9667"},"modified":"2026-03-18T11:22:37","modified_gmt":"2026-03-18T03:22:37","slug":"la-eof-griega-reabre-la-plataforma-para-las-declaraciones-de-autenticidad-en-los-envases-farmaceuticos","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/","title":{"rendered":"La EOF de Grecia reabre la plataforma para la verificaci\u00f3n de autenticidad de cintas..."},"content":{"rendered":"<p><span data-contrast=\"auto\">En\u00a0<\/span><b><span data-contrast=\"auto\">9 de marzo de 2026<\/span><\/b><span data-contrast=\"auto\">, la Organizaci\u00f3n Nacional de Medicamentos anunci\u00f3 la reapertura temporal de su plataforma de env\u00edo digital para la\u00a0<\/span><b><span data-contrast=\"auto\">Cintas de declaraci\u00f3n de autenticidad adheridas al envase farmac\u00e9utico.<\/span><\/b><span data-contrast=\"auto\">. La actualizaci\u00f3n se dirige espec\u00edficamente a\u00a0<\/span><b><span data-contrast=\"auto\">Titulares de la autorizaci\u00f3n de comercializaci\u00f3n (MAH, por sus siglas en ingl\u00e9s)<\/span><\/b><span data-contrast=\"auto\">\u00a0y\u00a0<\/span><b><span data-contrast=\"auto\">Representantes locales responsables de los medicamentos comercializados en Grecia<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">El plazo de presentaci\u00f3n est\u00e1 abierto desde\u00a0<\/span><b><span data-contrast=\"auto\">09 de marzo de 2026 a las 08:00 al 10 de marzo de 2026 a las 23:59<\/span><\/b><span data-contrast=\"auto\">, permitiendo a las partes interesadas declarar la autenticidad de las cintas que fueron\u00a0<\/span><b><span data-contrast=\"auto\">Ya se aplicaban a los envases farmac\u00e9uticos, pero no se notificaron antes de la fecha l\u00edmite legal original del 20 de febrero de 2026.<\/span><\/b><span data-contrast=\"auto\">. Esta iniciativa forma parte de la aplicaci\u00f3n de la ley por parte de EOF.\u00a0<\/span><b><span data-contrast=\"auto\">Normativa sobre serializaci\u00f3n farmac\u00e9utica y lucha contra la falsificaci\u00f3n<\/span><\/b><span data-contrast=\"auto\">\u00a0de conformidad con la legislaci\u00f3n griega aplicable.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<div class=\"row\"  id=\"row-1575868383\">\n\n\t<div id=\"col-647358821\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-907815335\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-907815335 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>Detalles de la actualizaci\u00f3n<\/h2>\n\t<div id=\"gap-505881843\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-505881843 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">La plataforma reabierta proporciona una\u00a0<\/span><b><span data-contrast=\"auto\">Oportunidad limitada para la doble confirmaci\u00f3n de la autenticidad de la grabaci\u00f3n<\/span><\/b><span data-contrast=\"auto\">. Esta medida permite a los titulares de la autorizaci\u00f3n de comercializaci\u00f3n y a los representantes locales presentar declaraciones para las cintas que anteriormente se hab\u00edan omitido en las presentaciones previstas para la fecha l\u00edmite.\u00a0<\/span><b><span data-contrast=\"auto\">Fecha l\u00edmite: 20 de febrero de 2026<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">El plazo para la declaraci\u00f3n est\u00e1 estrictamente limitado a\u00a0<\/span><b><span data-contrast=\"auto\">cintas de autenticidad que ya se han aplicado a los envases farmac\u00e9uticos.<\/span><\/b><span data-contrast=\"auto\">\u00a0pero no se reportaron durante el per\u00edodo de reporte inicial. Ninguna solicitud nueva est\u00e1 contemplada en esta reapertura.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">EOF enfatiza que\u00a0<\/span><b><span data-contrast=\"auto\">Se requiere un cumplimiento r\u00e1pido y completo.<\/span><\/b><span data-contrast=\"auto\">, se\u00f1alando que la falta continua de informar sobre la autenticidad de las cintas puede conducir a\u00a0<\/span><b><span data-contrast=\"auto\">acciones o sanciones de cumplimiento normativo<\/span><\/b><span data-contrast=\"auto\">. La actualizaci\u00f3n refuerza el enfoque del regulador en\u00a0<\/span><b><span data-contrast=\"auto\">Trazabilidad, autenticidad del producto y medidas de seguridad contra la falsificaci\u00f3n en la cadena de suministro farmac\u00e9utico en Grecia.<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-647358821 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-882396669\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Fecha l\u00edmite para comentarios<\/h2>\n\t<div id=\"gap-656994545\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-656994545 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW230829425 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW230829425 BCX0\">La plataforma de env\u00edo EOF para declarar cintas de autenticidad no reportadas previamente permanecer\u00e1 abierta.\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW230829425 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW230829425 BCX0\">de <strong>Del 9 de marzo de 2026 (08:00) al 10 de marzo de 2026 (23:59)<\/strong><\/span><\/span><strong><span class=\"TextRun SCXW230829425 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW230829425 BCX0\">.<\/span><\/span><span class=\"EOP SCXW230829425 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-882396669 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-335780084\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Por qu\u00e9 es importante<\/h2>\n\t<div id=\"gap-2108041375\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2108041375 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Esta actualizaci\u00f3n refuerza la supervisi\u00f3n regulatoria relacionada con <strong>serializaci\u00f3n y cumplimiento de las normas contra la falsificaci\u00f3n<\/strong> en el mercado farmac\u00e9utico griego. Al proporcionar un breve per\u00edodo de reapertura para las declaraciones, EOF apoya una mejor\u00eda <strong>precisi\u00f3n de los datos, trazabilidad y transparencia de la cadena de suministro,<\/strong> mientras se mantiene <strong>Coherencia normativa y m\u00ednima interrupci\u00f3n operativa<\/strong> para las empresas afectadas.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-335780084 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1223749220\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Para qui\u00e9n es relevante<\/h2>\n\t<div id=\"gap-724405680\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-724405680 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>El anuncio es particularmente relevante para <strong>Titulares de la autorizaci\u00f3n de comercializaci\u00f3n, representantes farmac\u00e9uticos locales, equipos de asuntos regulatorios, profesionales de garant\u00eda de calidad y equipos de cumplimiento.<\/strong> responsable de la <strong>Distribuci\u00f3n, notificaci\u00f3n y supervisi\u00f3n regulatoria de medicamentos en Grecia. <\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1223749220 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1226752389\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Pr\u00f3ximos pasos<\/h2>\n\t<div id=\"gap-1456429844\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1456429844 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">Los equipos reguladores deber\u00edan\u00a0<\/span><b><span data-contrast=\"auto\">revisar los registros de autenticidad de las solicitudes de cinta<\/span><\/b><span data-contrast=\"auto\">\u00a0y cotejarlos con\u00a0<\/span><b><span data-contrast=\"auto\">Presentaciones anteriores realizadas antes de la fecha l\u00edmite del 20 de febrero de 2026<\/span><\/b><span data-contrast=\"auto\">. Cualquier omisi\u00f3n debe identificarse r\u00e1pidamente y las declaraciones requeridas deben enviarse a trav\u00e9s de la plataforma EOF.\u00a0<\/span><b><span data-contrast=\"auto\">dentro del per\u00edodo de reapertura del 9 al 10 de marzo de 2026<\/span><\/b><span data-contrast=\"auto\">\u00a0para evitar posibles riesgos de incumplimiento.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Las organizaciones que operan en m\u00faltiples mercados regulados a menudo se enfrentan a actualizaciones regulatorias similares con poca antelaci\u00f3n. Plataformas como\u00a0<\/span><b><span data-contrast=\"auto\">RegASK<\/span><\/b><span data-contrast=\"auto\">\u00a0Ayudar a los equipos de cumplimiento normativo y regulatorio a supervisar los cambios, realizar un seguimiento de las obligaciones y agilizar las presentaciones en todas las jurisdicciones.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/es\/\"><strong>RegASK<\/strong><\/a>\u00a0Es una plataforma l\u00edder de inteligencia regulatoria y orquestaci\u00f3n de flujos de trabajo con IA agentic que permite a organizaciones globales en sectores altamente regulados, como productos de consumo y ciencias de la vida, gestionar de forma proactiva entornos regulatorios complejos. Al combinar IA agentic avanzada con expertos en el sector,\u00a0<a href=\"http:\/\/regask.com\/es\/\"><strong>RegASK<\/strong><\/a>\u00a0Ofrece informaci\u00f3n predictiva y pr\u00e1ctica en tiempo real, as\u00ed como automatizaci\u00f3n integral, lo que agiliza los procesos de cumplimiento, mitiga los riesgos y acelera el acceso al mercado en m\u00e1s de 160 pa\u00edses. <a href=\"http:\/\/regask.com\/es\/\"><strong>M\u00e1s informaci\u00f3n <\/strong><\/a>o<a href=\"https:\/\/regask.com\/es\/reservar-una-demostracion\/\"><strong> Reserve una demostraci\u00f3n ahora.<\/strong><\/a><\/span><strong>\u00a0<\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1226752389 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-461137082\">\n\n\t<div id=\"col-746020526\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<div class=\"is-divider divider clearfix\" style=\"margin-top:2em;margin-bottom:2em;max-width:20%;height:1px;background-color:#a5acd9;\"><\/div>\n<h3>Preguntas frecuentes<\/h3>\n\t<div id=\"gap-481405061\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-481405061 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><span class=\"TextRun MacChromeBold SCXW267956491 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW267956491 BCX0\" data-ccp-parastyle=\"heading 3\">\u00bfCu\u00e1les son las nuevas directrices del CDE sobre los ensayos cl\u00ednicos de la vacuna contra la gripe?<\/span><\/span><span class=\"EOP SCXW267956491 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-484020777\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-484020777 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><strong>Reuniones de cartera y tecnolog\u00eda (PTM)<\/strong> son reuniones virtuales estructuradas organizadas por el <strong>Agencia Europea de Medicamentos<\/strong> para permitir que las grandes compa\u00f1\u00edas farmac\u00e9uticas discutan <strong>Desaf\u00edos en el desarrollo de la cartera de productos y tecnolog\u00edas emergentes<\/strong> con el regulador.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-746020526 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-362572415\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW184197477 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW184197477 BCX0\" data-ccp-parastyle=\"heading 3\">\u00bfQui\u00e9nes pueden solicitar participar en las reuniones de EMA sobre cartera de proyectos y tecnolog\u00eda?<\/span><\/span><span class=\"EOP SCXW184197477 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-843942117\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-843942117 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>El programa PTM est\u00e1 abierto a <strong>Grandes compa\u00f1\u00edas farmac\u00e9uticas con amplias carteras de productos medicinales.<\/strong> Las empresas que cumplan los requisitos deber\u00e1n presentar un formulario de solicitud a la EMA para su revisi\u00f3n.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-362572415 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1517995368\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW3460145 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW3460145 BCX0\" data-ccp-parastyle=\"heading 3\">\u00bfCu\u00e1l es el plazo para solicitar una beca PTM en 2026?<\/span><\/span><span class=\"EOP SCXW3460145 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-709754190\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-709754190 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>El <strong>La fecha l\u00edmite para presentar la solicitud es el 30 de abril de 2026.<\/strong> El <strong>La EMA comunicar\u00e1 los resultados de las solicitudes a finales de mayo de 2026.,<\/strong> y las reuniones aprobadas tendr\u00e1n lugar en el <strong>segunda mitad de 2026. <\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1517995368 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-648561700\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW14904628 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW14904628 BCX0\" data-ccp-parastyle=\"heading 3\">\u00bfC\u00f3mo puedo?\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW14904628 BCX0\" data-ccp-parastyle=\"heading 3\">RegASK<\/span><span class=\"NormalTextRun SCXW14904628 BCX0\" data-ccp-parastyle=\"heading 3\">\u00a0\u00bfC\u00f3mo ayudan las organizaciones a gestionar actualizaciones como esta?<\/span><\/span><span class=\"EOP SCXW14904628 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-933115969\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-933115969 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun MacChromeBold SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/es\/\"><strong><span class=\"NormalTextRun SpellingErrorV2Themed SCXW253285960 BCX0\">RegASK<\/span><\/strong><\/a><span class=\"NormalTextRun SCXW253285960 BCX0\">\u00a0<strong>Plataforma de inteligencia regulatoria basada en IA con agentes<\/strong><\/span><\/span><span class=\"TextRun SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\">ayuda a las compa\u00f1\u00edas farmac\u00e9uticas\u00a0<\/span><\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">monitor<\/span><strong><span class=\"TextRun MacChromeBold SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\">Anuncios regulatorios globales, oportunidades de participaci\u00f3n y programas de consulta.<\/span><\/span><\/strong><span class=\"TextRun SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\">\u00a0en tiempo real. Esto permite a los equipos reguladores\u00a0<\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">identificar<\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">\u00a0iniciativas como\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\">Reuniones sobre la cartera de productos y la tecnolog\u00eda de la EMA<\/span><\/span><\/strong><span class=\"TextRun SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\"><strong>,<\/strong> coordinar la preparaci\u00f3n interna y\u00a0<\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">mantener<\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">\u00a0Preparaci\u00f3n para el cumplimiento normativo en oleoductos globales complejos.<\/span><\/span><span class=\"EOP SCXW253285960 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-648561700 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>El 9 de marzo de 2026, la Organizaci\u00f3n Nacional de Medicamentos anunci\u00f3 la reapertura temporal de su plataforma digital para la presentaci\u00f3n de declaraciones de autenticidad en los envases farmac\u00e9uticos. Esta actualizaci\u00f3n est\u00e1 dirigida espec\u00edficamente a los titulares de la autorizaci\u00f3n de comercializaci\u00f3n (TAC) y a los representantes locales responsables de los medicamentos comercializados en Grecia. El plazo de presentaci\u00f3n est\u00e1 abierto desde el 9 de marzo de 2026 a las 8:00 h hasta el 10 de marzo de 2026 a las\u2026<\/p>","protected":false},"author":43,"featured_media":9668,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33,35,556],"tags":[],"class_list":["post-9667","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-pharma-biotech-latest-insights","category-greece-regulations"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.8 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Greece\u2019s EOF Reopens Platform for Compliance Updates<\/title>\n<meta name=\"description\" content=\"Greece\u2019s EOF reopens the platform for authenticity tape declarations on pharmaceutical packaging from March 9 to March 10, 2026.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/la-eof-griega-reabre-la-plataforma-para-las-declaraciones-de-autenticidad-en-los-envases-farmaceuticos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Greece\u2019s EOF Reopens Platform for Authenticity Tape Declarations on Pharmaceutical Packaging\" \/>\n<meta property=\"og:description\" content=\"Greece\u2019s EOF reopens the platform for authenticity tape declarations on pharmaceutical packaging from March 9 to March 10, 2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/la-eof-griega-reabre-la-plataforma-para-las-declaraciones-de-autenticidad-en-los-envases-farmaceuticos\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-18T03:22:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"Greece\u2019s EOF Reopens Platform for Authenticity Tape D&hellip;\",\"datePublished\":\"2026-03-18T03:22:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\"},\"wordCount\":822,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\",\"articleSection\":[\"Regulatory News\",\"Pharma and Biotech\",\"Greece\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\",\"name\":\"Greece\u2019s EOF Reopens Platform for Compliance Updates\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\",\"datePublished\":\"2026-03-18T03:22:37+00:00\",\"description\":\"Greece\u2019s EOF reopens the platform for authenticity tape declarations on pharmaceutical packaging from March 9 to March 10, 2026.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\",\"width\":800,\"height\":600,\"caption\":\"Greece Eof Reopens Platform Authenticity Tape Declarations Pharmaceutical Packaging\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"El EOF de Grecia reabre su plataforma para actualizaciones de cumplimiento.","description":"La EOF griega reabre la plataforma para las declaraciones de autenticidad en los envases farmac\u00e9uticos desde el 9 hasta el 10 de marzo de 2026.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/la-eof-griega-reabre-la-plataforma-para-las-declaraciones-de-autenticidad-en-los-envases-farmaceuticos\/","og_locale":"es_ES","og_type":"article","og_title":"Greece\u2019s EOF Reopens Platform for Authenticity Tape Declarations on Pharmaceutical Packaging","og_description":"Greece\u2019s EOF reopens the platform for authenticity tape declarations on pharmaceutical packaging from March 9 to March 10, 2026.","og_url":"https:\/\/regask.com\/es\/la-eof-griega-reabre-la-plataforma-para-las-declaraciones-de-autenticidad-en-los-envases-farmaceuticos\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-03-18T03:22:37+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Reva Ananda","Est. reading time":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#article","isPartOf":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"Greece\u2019s EOF Reopens Platform for Authenticity Tape D&hellip;","datePublished":"2026-03-18T03:22:37+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/"},"wordCount":822,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","articleSection":["Regulatory News","Pharma and Biotech","Greece"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/","url":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/","name":"El EOF de Grecia reabre su plataforma para actualizaciones de cumplimiento.","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","datePublished":"2026-03-18T03:22:37+00:00","description":"La EOF griega reabre la plataforma para las declaraciones de autenticidad en los envases farmac\u00e9uticos desde el 9 hasta el 10 de marzo de 2026.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","width":800,"height":600,"caption":"Greece Eof Reopens Platform Authenticity Tape Declarations Pharmaceutical Packaging"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"El sistema operativo de IA regulatoria para equipos de alto rendimiento","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"Reva Ananda"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/9667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=9667"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/9667\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/9668"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=9667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=9667"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=9667"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}